Erratum: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Leukemia (2012) 26 (149-157) DOI: 10.1038/leu.2011.196)
- Kumar, S.K.
- Lee, J.H.
- Lahuerta, J.J.
- Morgan, G.
- Richardson, P.G.
- Crowley, J.
- Haessler, J.
- Feather, J.
- Hoering, A.
- Moreau, P.
- Leleu, X.
- Hulin, C.
- Klein, S.K.
- Sonneveld, P.
- Siegel, D.
- Bladeé, J.
- Goldschmidt, H.
- Jagannath, S.
- Miguel, J.S.
- Orlowski, R.
- Palumbo, A.
- Sezer, O.
- Rajkumar, S.V.
ISSN: 0887-6924, 1476-5551
Argitalpen urtea: 2012
Alea: 26
Zenbakia: 5
Orrialdeak: 1153
Mota: Hutsen zuzenketa